On the move: the latest East Midlands hires
Land promoter Richborough has appointed chartered town planner Mark Dauncey.
With 20 years of housing and mixed-use industry experience, Dauncey brings a wealth of knowledge to Richborough following senior positions at Stantec, Amos Group and Pegasus Group, and joins the firm as it continues to expand following investment from Terra Firma in 2022.
Dauncey is joining Richborough’s East division as planning director. The region has considerably grown in the last 12-months with a current portfolio of 40 live sites that will bring forward 8,200 new homes. Dauncey will oversee planning activity for the region’s portfolio working alongside regional director Anabel Christmas, regional manager Andrew Miekle and land and planning manager, Briony Stenhouse.
Dauncey said: “With government aims to provide 1.5million new homes in five years to help resolve the UK’s long-running housing crisis, and changes in planning legislation expected to unlock potential residential sites, East Midlands local authorities have seen their targets dramatically change under the new methodology devised as part of the proposed revisions to the National Planning Policy Framework.
“If approved, local authorities will be facing increasing pressure to deliver new homes. Richborough is well placed to help work with landowners and housebuilders to help meet this ambitious target and I’ve long admired their innovative approach to land promotion. It’s an exciting time to join the firm.”
Christmas said: “This is a huge time of flux for our industry with much-needed change on the way to help deliver the homes the region needs, North East Derbyshire alone has seen its targets increase by 178%*. Mark’s expertise will greatly assist our team to ensure we bring forward sustainable and sensible site proposals that benefit their local communities, whilst still helping to meet these ambitious targets.”
Roger Teasdale
A new chair has been appointed by Nottingham ocular tissue-therapy company NuVision Biotherapies.
Roger Teasdale, who has been a non-executive director at NuVision since 2017, will bring extensive experience in the healthcare industry to his new role. He previously spent over 25 years at British multinational medical equipment firm, Smith & Nephew, where he served five years as President of the Advanced Wound Management Division.
The announcement comes as Mark Treherne steps down from the role to serve as an independent non-executive director after six years of leadership.
Teasdale said: “It’s a real privilege to take on the role of chair at such an innovative company. My experience as a non-executive director since 2017 has given me a deep understanding of NuVision’s mission and goals. I look forward to building on this foundation as we expand into new markets and bring our transformative eye treatments to more people in need.”
NuVision’s CEO, Andy Hill, added: “It is a privilege to have Roger step into the role of chairman. His deep understanding of NuVision and the industry will be vital as we continue to drive innovation and growth in the UK and internationally. We also want to extend our gratitude to Mark Treherne for his valuable contributions over the past six years.”
